Factors influencing urinary symptoms 10 years after permanent prostate seed implantation

Journal of Urology

Volumn 187, Issue 1, 2012, Pages 117-123

  Stone, Nelson N ^a   Gerber, Naamit Kurshan ^a   Blacksburg, Seth ^a   Stone, Jonathan ^a   Stock, Richard G ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

brachytherapy; prostatic neoplasms; quality of life; radiotherapy; treatment outcome

Indexed keywords

IODINE 125; PALLADIUM 103;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; EXTERNAL BEAM RADIOTHERAPY; HORMONAL THERAPY; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PREMEDICATION; PRIORITY JOURNAL; PROSTATE SEED IMPLANTATION; RADIATION DOSE; RISK FACTOR; SCORING SYSTEM; URINARY TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; TIME FACTORS; UROLOGIC DISEASES;

EID: 83555160931     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.09.045     Document Type: Article

References (29)

1. S.H. Aaltomaa, V.V. Kataja, and T. Lahtinen Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapymorbidity and outcome results Radiother Oncol 91 2009 213
2. J. Crook, N. Fleshner, and C. Roberts Long-term urinary sequelae following 125iodine prostate brachytherapy J Urol 179 2008 141
3. G.S. Merrick, W.M. Butler, and K.E. Wallner Long-term urinary quality of life after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 56 2003 454
4. M.D. Terk, R.G. Stock, and N.N. Stone Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate J Urol 160 1998 1379
5. J. Desai, R.G. Stock, and N.N. Stone Acute urinary morbidity following I-125 interstitial implantation of the prostate gland Radiat Oncol Invest 6 1998 135
6. S. Lehrer, J. Cesaretti, and N.N. Stone Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation BJU Int 98 2006 979
7. K. Kelly, R. Swindell, and J. Routledge Prediction of urinary symptoms after 125iodine prostate brachytherapy Clin Oncol (R Coll Radiol) 18 2006 326
8. J. Bucci, W.J. Morris, and M. Keyes Predictive factors of urinary retention following prostate brachytherapy Int J Radiat Oncol Biol Phys 53 2002 91
9. J. Crook, M. McLean, and C. Catton Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation Int J Radiat Oncol Biol Phys 52 2002 453
10. N. Lee, C.S. Wuu, and R. Brody Factors predicting for postimplantation urinary retention after permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 1457
11. J. Locke, W. Ellis, and K. Wallner Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study Int J Radiat Oncol Biol Phys 52 2002 712
12. M.J. Wehle, S.W. Lisson, and S.J. Buskirk Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma Mayo Clin Proc 79 2004 314
13. N. Bittner, G.S. Merrick, and K.E. Wallner The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapy Brachytherapy 6 2007 258
14. N.N. Stone, and R.G. Stock Prostate brachytherapy: treatment strategies J Urol 162 1999 421
15. R.G. Stock, N.N. Stone, and M.F. Wesson A modified technique allowing interactive ultrasound guided three dimensional transperineal prostate implantation Int J Radiat Oncol Biol Phys 32 1995 219
16. N.N. Stone, D.T. Marshall, and J.J. Stone Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy? J Urol 183 2010 634
17. R.G. Stock, N.N. Stone, and J.A. Cesaretti Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results Int J Radiat Oncol Biol Phys 64 2006 527
18. S. Gutman, G.S. Merrick, and W.M. Butler Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy BJU Int 97 2006 62
19. G.S. Merrick, W.M. Butler, and J.H. Lief Temporal resolution of urinary morbidity following prostate brachytherapy Int J Radiat Oncol Biol Phys 47 2000 121
20. D. Ash, D. Bottomley, and B. Al-Qaisieh A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localized prostate cancer Radiother Oncol 84 2007 135
21. D. Landis, K. Wallner, and J. Locke Late urinary function after prostate brachytherapy Brachytherapy 1 2002 21
22. D. Vordermark, M. Noe, and K. Markert Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate V150 Radiother Oncol 91 2009 217
23. A. Niehaus, G.S. Merrick, and W.M. Butler The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy Int J Radiat Oncol Biol Phys 64 2006 136
24. M. Pinkawa, K. Fischedick, and B. Gagel Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer Urology 68 2006 104
25. N.N. Stone, and R.G. Stock The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume J Urol 177 2007 925
26. N.N. Stone, L. Potters, and B.J. Davis Customized dose prescription for prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes Int J Radiat Oncol Biol Phys 69 2007 1472
27. N.N. Stone, R.G. Stock, and J.A. Cesaretti Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes Int J Radiat Oncol Biol Phys 76 2010 335
28. M.J. Rivard, W.M. Butler, and P.M. Devlin American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103 Brachytherapy 6 2007 34
29. S.A. Rosenthal, N.H. Bittner, and D.C. Beyer American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 79 2011 335